ACS Chemical Biology · 2013 · 57 citations · 24 references
PharmacyMedicinal ChemistryMolecular BiologyDrug DesignDrug DiscoveryEpigeneticsEnzyme InhibitionMolecular Mechanisms Of ToxicityChemical Structure-activity RelationshipsCytotoxicity AssaysDna MethyltransferasesHek293 Cell ExpressionLysine Methyltransferase Activity
In order to discover new inhibitors of the DNA methyltransferase 3A/3L complex, we used a medium-throughput nonradioactive screen on a random collection of 1120 small organic compounds. After a primary hit detection against DNA methylation activity of the murine Dnmt3A/3L catalytic complex, we further evaluated the EC50 of the 12 most potent hits as well as their cytotoxicity on DU145 prostate cancer cultured cells. Interestingly, most of the inhibitors showed low micromolar activities and little cytotoxicity. Dichlone, a small halogenated naphthoquinone, classically used as pesticide and fungicide, showed the lowest EC50 at 460 nM. We briefly assessed the selectivity of a subset of our new inhibitors against hDNMT1 and bacterial Dnmts, including M. SssI and EcoDam, and the protein lysine methyltransferase PKMT G9a and the mode of inhibition. Globally, the tested molecules showed a clear preference for the DNA methyltransferases, but poor selectivity among them. Two molecules including Dichlone efficiently reactivated YFP gene expression in a stable HEK293 cell line by promoter demethylation. Their efficacy was comparable to the DNMT inhibitor of reference 5-azacytidine.
24
Adrian Bird · Nature · 2007 · 2.9K citations · Full text
Protein lysine methyltransferase G9a acts on non-histone targets
Philipp Rathert, Arunkumar Dhayalan, Marie Murakami et al. · Nature Chemical Biology · 2008 · 336 citations · Full text
Mehrnaz Fatemi, Andrea Hermann, Shriharsa Pradhan et al. · Journal of Molecular Biology · 2001 · 267 citations
Jharna Datta, Kalpana Ghoshal, William A. Denny et al. · Cancer Research · 2009 · 264 citations · Full text